- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Enzon Pharmaceuticals Inc+ Add to Watchlist
ENZN:US1.4500 USD 0.00000.00%
As of 20:10:00 ET on 12/05/2013.
Company Profile for Enzon Pharmaceuticals Inc (ENZN)
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.
Enzon Pharmaceuticals Inc
Key Executives for Enzon Pharmaceuticals Inc (ENZN)
|George W Hebard IIIInterim Chief Operating Ofcr||Andrew RackearChief Compliance Ofcr/Secy|